Skip to main content

Table 1 Inclusion and exclusion criteria

From: Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study

Inclusion criteria Exclusion criteria
• Patients with advanced prostate cancer receiving Antiandrogen therapy for at least 4 weeks or • Anemia > 8 g/dl
• Platelet count ≤ 10000/μl
• COPD
• Patients with advanced prostate cancer receiving Antiandrogen therapy in combination with chemotherapy (baseline test before chemotherapy) • CNS Metastasis
• Epilepsy
• Planned Surgery
• Heart failure (NYHA III-IV)
• Hemoglobin > 9 g/dl • Coronary disease
• Ejection fraction ≥ 60% • Therapy refractory Hypertension
• Forced expiratory volume in one second ≥ 50% • Other internistic diseases that rule out exercise
• Orthopedic handicaps that rule out exercise
• Age ≥ 18 years • Psychological problems which are critical in view of the responsible medical doctor
• Expectation of life ≥ 6 month
• Written consent
• Inconspicuous ultrasound of the patients heart
• Inconspicuous ECG (rest and stress)